FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890920818> ?p ?o ?g. }

• W2890920818 endingPage "e16526" @default.
• W2890920818 startingPage "e16526" @default.
• W2890920818 abstract "e16526 Background: Although the survival benefit of neoadjuvant chemotherapy (NAC) in bladder cancer patients receiving radical cystectomy (RC) has been established, the NAC associated complication rate is not well-known, especially in elderly patients. Methods: We identified 427 patients who had undergone RC for clinical TanyN0M0 bladder cancer from 2005 to 2015 at our 7 institutions. Among them, 118 (27.6%) were treated with gemcitabine and cisplatin (GC)-NAC. The details of the complication rate during and after RC were recorded according to the Clavien-Dindo classification. We evaluated the association between the complication rate for RC with NAC and patient age. Results: Overall, 60 (14.0%), 306 (71.7%), and 61 (14.3%) patients were < 60, 60-79, and ≥ 80 years old, respectively. Overall, 190 (44.5%) patients had some kind of postoperative complication and there was no difference in the postoperative complication rate between the NAC and non-NAC groups (37.3% vs 47.2%: p = 0.065). However, the incidence rate of post-operative ileus in the NAC group was 9.3%, which was significantly lower than that in the non-NAC group (19.1%, p = 0.013). Sixteen (26.7%), 93 (30.4%) and 9 (14.8%) patients in the < 60, 60-79, and ≥ 80 age groups, respectively, received GC-NAC. Among patients < 60 years old, the complication rates for post-operative ileus, pyelonephritis and wound infection were 12.5%, 18.8%, and 0% in the NAC group, which were not significantly different from those in the non-NAC group (9.1%, 6.8%, and 13.6%, respectively). Among 60-79 year-old patients, the corresponding complication rates were 8.6%, 11.8%, and 9.7% in the NAC group, which were not significantly different from those in the non-NAC group (17.8%, 9.9%, and 9.4%, respectively). Among patients ≥ 80 years old, the rates were 11.1%, 11.1%, and 33.3% in the NAC group, which were not significantly different from those in the non-NAC group (28.8%, 11.5%, and 13.5%, respectively). Furthermore, in patients treated with GC-NAC, no association was observed in the complication rates among patients < 60 years, 60-79 years, and ≥ 80 years old. Conclusions: NAC could be provided safely at the time of RC regardless of patient age." @default.
• W2890920818 created "2018-09-27" @default.
• W2890920818 creator A5008830530 @default.
• W2890920818 creator A5017359886 @default.
• W2890920818 creator A5024156499 @default.
• W2890920818 creator A5063095736 @default.
• W2890920818 creator A5086644570 @default.
• W2890920818 date "2018-05-20" @default.
• W2890920818 modified "2023-09-23" @default.
• W2890920818 title "Does neoadjuvant chemotherapy affect postoperative complication rates in elderly patients treated with radical cystectomy for bladder cancer?" @default.
• W2890920818 doi "https://doi.org/10.1200/jco.2018.36.15_suppl.e16526" @default.
• W2890920818 hasPublicationYear "2018" @default.
• W2890920818 type Work @default.
• W2890920818 sameAs 2890920818 @default.
• W2890920818 citedByCount "0" @default.
• W2890920818 crossrefType "journal-article" @default.
• W2890920818 hasAuthorship W2890920818A5008830530 @default.
• W2890920818 hasAuthorship W2890920818A5017359886 @default.
• W2890920818 hasAuthorship W2890920818A5024156499 @default.
• W2890920818 hasAuthorship W2890920818A5063095736 @default.
• W2890920818 hasAuthorship W2890920818A5086644570 @default.
• W2890920818 hasConcept C120665830 @default.
• W2890920818 hasConcept C121332964 @default.
• W2890920818 hasConcept C121608353 @default.
• W2890920818 hasConcept C126322002 @default.
• W2890920818 hasConcept C141071460 @default.
• W2890920818 hasConcept C2775910329 @default.
• W2890920818 hasConcept C2776694085 @default.
• W2890920818 hasConcept C2777125728 @default.
• W2890920818 hasConcept C2778239845 @default.
• W2890920818 hasConcept C2780258809 @default.
• W2890920818 hasConcept C2780352672 @default.
• W2890920818 hasConcept C61511704 @default.
• W2890920818 hasConcept C71924100 @default.
• W2890920818 hasConcept C81182388 @default.
• W2890920818 hasConceptScore W2890920818C120665830 @default.
• W2890920818 hasConceptScore W2890920818C121332964 @default.
• W2890920818 hasConceptScore W2890920818C121608353 @default.
• W2890920818 hasConceptScore W2890920818C126322002 @default.
• W2890920818 hasConceptScore W2890920818C141071460 @default.
• W2890920818 hasConceptScore W2890920818C2775910329 @default.
• W2890920818 hasConceptScore W2890920818C2776694085 @default.
• W2890920818 hasConceptScore W2890920818C2777125728 @default.
• W2890920818 hasConceptScore W2890920818C2778239845 @default.
• W2890920818 hasConceptScore W2890920818C2780258809 @default.
• W2890920818 hasConceptScore W2890920818C2780352672 @default.
• W2890920818 hasConceptScore W2890920818C61511704 @default.
• W2890920818 hasConceptScore W2890920818C71924100 @default.
• W2890920818 hasConceptScore W2890920818C81182388 @default.
• W2890920818 hasIssue "15_suppl" @default.
• W2890920818 hasLocation W28909208181 @default.
• W2890920818 hasOpenAccess W2890920818 @default.
• W2890920818 hasPrimaryLocation W28909208181 @default.
• W2890920818 hasRelatedWork W2317145945 @default.
• W2890920818 hasRelatedWork W2398744750 @default.
• W2890920818 hasRelatedWork W2603025253 @default.
• W2890920818 hasRelatedWork W2751375968 @default.
• W2890920818 hasRelatedWork W2964723749 @default.
• W2890920818 hasRelatedWork W3031752735 @default.
• W2890920818 hasRelatedWork W3031949156 @default.
• W2890920818 hasRelatedWork W3049060893 @default.
• W2890920818 hasRelatedWork W3202515919 @default.
• W2890920818 hasRelatedWork W4233827388 @default.
• W2890920818 hasVolume "36" @default.
• W2890920818 isParatext "false" @default.
• W2890920818 isRetracted "false" @default.
• W2890920818 magId "2890920818" @default.
• W2890920818 workType "article" @default.